A nurse caring for a client receiving doxycycline (Doryx) for the treatment of Lyme's Disease. Which statement below should be included in the client teaching plan?

A) This medication may cause discoloration of the teeth:
Doxycycline is a tetracycline-class antibiotic, and like other drugs in this group, it can bind to calcium in developing teeth, leading to permanent discoloration if taken during childhood or by pregnant or breastfeeding women whose fetuses or infants are exposed to the drug. In adults, it can still cause temporary staining, especially with prolonged use. Patients should be informed about this potential side effect to prevent concern and encourage good oral hygiene.

B) This medication should not be taken if you are lactating:
Doxycycline is generally considered compatible with breastfeeding, although it should be used with caution. While doxycycline does pass into breast milk, the risk to an infant is minimal, particularly for short-term use. However, the safety profile may vary depending on the infant's age and health, and a healthcare provider should evaluate the risks and benefits in each case.

C) This medication should not be taken with antacids:
Antacids containing calcium, magnesium, or aluminum can interfere with the absorption of doxycycline. These minerals bind to the antibiotic in the gastrointestinal tract, decreasing its effectiveness. It is recommended to space the administration of doxycycline and antacids by at least 2 hours to ensure adequate absorption of the medication. This is a key consideration in managing patients taking doxycycline.

D) This medication can cause hyperglycemia:
Doxycycline is not typically associated with hyperglycemia. Hyperglycemia is not a common or expected side effect of this medication. Doxycycline's side effects more commonly involve gastrointestinal distress, photosensitivity, and potential effects on the liver or kidneys. Hyperglycemia would be more likely in a diabetic patient on steroids or other specific medications, not generally with doxycycline.

E) This medication should not be administered to anyone under the age of 20 years old:
Doxycycline is contraindicated in children under 8 years old due to the risk of tooth discoloration and impaired bone development, not generally in those under 20 years of age. While it may be used with caution in adolescents for specific infections, the drug is not recommended for younger children. However, there is no blanket restriction for those under 20, especially if the benefits outweigh the risks.

F) This medication may cause photosensitivity:
Doxycycline can increase the skin’s sensitivity to sunlight, resulting in an increased risk of sunburn or skin rash. This is a well-known side effect of tetracycline antibiotics, and patients taking doxycycline should be advised to avoid prolonged sun exposure, wear sunscreen, and protective clothing to reduce the risk of photosensitivity reactions.

A) Multiple Sclerosis:
Multiple sclerosis (MS) is a neurological condition characterized by demyelination of nerve fibers in the central nervous system. While MS is a chronic condition that requires careful management, it is not a contraindication for taking sulfamethoxazole/trimethoprim (Bactrim). There is no direct interaction between Bactrim and MS, so the use of this medication in a patient with MS would not typically be contraindicated. However, caution should be exercised if the patient is on other medications that may interact with Bactrim.

B) Chronic kidney disease (CKD):
Sulfamethoxazole/trimethoprim (Bactrim) is contraindicated in patients with severe chronic kidney disease (CKD), particularly in those with a creatinine clearance of less than 15 mL/min. This is because Bactrim is primarily excreted by the kidneys, and impaired renal function increases the risk of drug accumulation, leading to toxicity. In patients with CKD, Bactrim can also increase the risk of hyperkalemia (elevated potassium levels) and other renal complications. If the patient has mild to moderate CKD, the dosage of Bactrim may need to be adjusted, but it should not be used in severe CKD without careful monitoring.

C) Megaloblastic anemia:
Megaloblastic anemia is caused by a deficiency of folate (vitamin B12 or folate deficiency) and is not a direct contraindication for sulfamethoxazole/trimethoprim. However, trimethoprim, one of the components of Bactrim, can interfere with folate metabolism by inhibiting dihydrofolate reductase, which may exacerbate megaloblastic anemia in susceptible individuals. This is especially a concern in patients with pre-existing folate deficiency or those who are at risk for developing it. In these cases, folic acid supplementation may be recommended, but megaloblastic anemia alone does not outright contraindicate Bactrim use.

D) Helicobacter pylori:
Helicobacter pylori is a bacterium commonly associated with peptic ulcers, and it is typically treated with a combination of antibiotics (e.g., clarithromycin, amoxicillin, and proton pump inhibitors). Sulfamethoxazole/trimethoprim (Bactrim) is not typically used to treat H. pylori infections, but it is not a contraindication for its use. Bactrim does not have an effect on H. pylori directly, but it would not be contraindicated simply because the patient has an H. pylori infection. Bactrim’s use would be based on the presence of a urinary tract infection, not the presence of H. pylori.